About Yahoo Finance: Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life. - Get the latest news and data at finance.yahoo.com - Download the Yahoo Finance app on Apple (https://apple.co/3Rten0R) or Android (https://bit.ly/3t8UnXO) - Follow Yahoo Finance on social: X: http://twitter.com/YahooFinance Instagram: https://www.instagram.com/yahoofinance/?hl=en TikTok: https://www.tiktok.com/@yahoofinance?lang=en Facebook: https://www.facebook.com/yahoofinance/ LinkedIn: https://www.linkedin.com/company/yahoo-finance
Tariffs are supposed to temper margins and earnings prospects outside the United States. With the energy sector significantly compressed by low crude oil prices, this double headwind doesn't bode well for stocks exposed to this space, especially overseas companies.
Dell vs. HPE: Which AI Infrastructure Stock Is the Better Buy Now? — Positive
DELL HPE Zacks Investment Research — October 13, 2025DELL's AI server boom and expanding edge portfolio give it a strong lead over HPE in the fast-growing AI infrastructure market.
Reddit Rises 21% Year to Date: Buy, Sell, or Hold the Stock? — Positive
RDDT Zacks Investment Research — October 13, 2025RDDT's growth is driven by strong engagement, ad innovation, and global expansion, thereby enhancing investors' optimism.
JPMorgan Chase says it will invest $10 billion into industries critical for national security — Positive
JPM CNBC Television — October 13, 2025JPMorgan Chase on Monday said it is launching a decade-long plan to help finance and take direct stakes in companies it considers crucial to U.S. interests. The bank said in a statement it would invest up to $10 billion into companies in four areas: defense and aerospace, “frontier” technologies including artificial intelligence and quantum computing, energy technology including batteries, and supply chain and advanced manufacturing.
Tvardi Therapeutics' Lung Disease Candidate Fails To Show Any Clinical Benefit, Stock Sinks — Negative
TVRD Benzinga — October 13, 2025Tvardi Therapeutics Inc. (NASDAQ:TVRD) stock is falling on Monday with a session volume of 5.56 million versus the average volume of 42.08 thousand, as per data from Benzinga Pro.
Amazon and TikTok are helping Estee Lauder reinvent itself, Goldman Sachs says — Positive
AMZN EL Market Watch — October 13, 2025Cosmetics giant Estee Lauder Cos.'s rebound could take hold sooner than expected, Goldman Sachs analysts said on Monday, as trends firm up in the U.S. and China and the company puts more focus on newer and higher-end products and sales through TikTok and Amazon.
Atai Life Sciences Remains Undervalued, Analyst Initiates With Around 125% Stock Upside — Positive
ATAI Benzinga — October 13, 2025Needham on Monday initiated coverage on Atai Life Sciences NV (NASDAQ:ATAI), a clinical-stage biopharmaceutical company focused on developing treatments for mental health.
NII & Fee Income to Aid Fifth Third's Q3 Earnings, High Costs to Hurt — Neutral
FITB Zacks Investment Research — October 13, 2025FITB's Q3 earnings are likely to rise on stronger NII and fee income, but higher expenses could weigh on results.
Duke Energy Corporation leverages its leading regulated nuclear portfolio and $87 billion capital plan to capture datacenter-driven demand growth. DUK's recent asset sales generated $7.5 billion, supporting debt reduction, equity needs, and funding for ambitious infrastructure expansion. With a 6% EPS growth target, 3.5% dividend yield, and disciplined payout ratio, DUK aims for ~10% total annual shareholder returns.
Broadcom-OpenAI deal expected to be cheaper than current GPU options — Positive
AVGO CNBC Television — October 13, 2025CNBC's MacKenzie Sigalos reports on news regarding OpenAI and Broadcom.
‘All that glitters is fear' as $5,000 gold is now ‘increasingly inevitable' – Societe Generale — Neutral
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — October 13, 2025Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.
INSP Shares Down Despite Strong Clinical Data From Inspire V Trials — Neutral
INSP Zacks Investment Research — October 13, 2025Inspire Medical's Inspire V system shows strong safety, faster surgeries, and higher patient adherence in new trials.
BD Stock Down Despite Making Progress in the Treatment of PAD Lesions — Negative
BDX Zacks Investment Research — October 13, 2025BDX advances PAD care with first patient enrolled in the XTRACT Registry using its dual-action Rotarex system.
Zoetis Gains CVMP Backing for Lenivia, Eyes EU Approval in Dog OA Pain — Positive
ZTS Zacks Investment Research — October 13, 2025ZTS secures CVMP's positive opinion recommending the approval of Lenivia, a long-acting OA pain therapy for dogs, with the final decision expected in late 2025.
T Shares Rise 20% in the Past Year: Should You Invest Now? — Positive
T Zacks Investment Research — October 13, 2025AT&T's 20% stock surge outpaces industry growth as heavy network and AI investments drive long-term momentum amid stiff competition.
2 Stocks in Focus as New Analyst Initiates Coverage — Positive
BULL WW Zacks Investment Research — October 13, 2025New analyst coverage sparks fresh interest in WW and BULL as both stocks show stable 2025 forecasts despite recent declines.
aTyr Pharma, Inc.'s (ATYR) Failed Drug Trial Spurs Securities Lawsuit -- Hagens Berman — Neutral
ATYR GlobeNewsWire — October 13, 2025SAN FRANCISCO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- A federal class-action lawsuit has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) following a devastating 83% drop in the biotech company's stock price after its lead drug candidate failed to meet its primary endpoint in a critical Phase 3 trial.
MP Materials Stock, USA Rare Earth Climb Amid U.S.-China Trade Spat — Neutral
MP USAR Investopedia — October 13, 2025U.S. rare-earths stocks are hot to start the week.
